Brightheart Veterinary Centers Participates in New Clinical Trials for Dogs with Lymphoma

BrightHeart Veterinary Centers are excited to announce the opening of a clinical trial investigating a novel medication for dogs with lymphoma. The purpose of this study is to evaluate the safety and efficacy of a new investigational medication for the treatment of lymphoma. Dogs will receive chemotherapy (doxorubicin) and the new study medication every 3 weeks for up to 5 treatments. Dogs must be evaluated at a BrightHeart network hospital (Katonah-Bedford Veterinary Center in Bedford Hills, NY or South Paws in Fairfax, VA) initially and then again at weeks 1, 3, 6, 9, 12 and 15.

We are actively recruiting canine patients with lymphoma for this clinical trial -- so if you have a patient with lymphoma, before you start any treatment, please call to see if your patient is eligible. To qualify, patients must have a definitive diagnosis and meet specific inclusion criteria. For enrolled patients, all diagnostic and treatment costs are covered by the study!

Enrollment

Please call Dr. Philip Bergman (Katonah Bedford Veterinary Center) at 914-241-7700, Dr. Sarah Sheafor (SouthPaws Veterinary Specialists) at 703-752-9103, or consult www.brightheartvet.com for more information on patient enrollment or participating BrightHeart locations.

Back to Clinical Trials Main Page >